Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
Weltermann A, Fonatsch C, Haas OA, Greinix HT, Kahls P, Mitterbauer G, Jäger U, Kainz B, Geissler K, Valent P, Sperr WR, Knöbl P, Schwarzinger I, Gleiss A, Lechner K.
Weltermann A, et al. Among authors: fonatsch c.
Leukemia. 2004 Feb;18(2):293-302. doi: 10.1038/sj.leu.2403243.
Leukemia. 2004.
PMID: 14671635